In 2023, Antiretroviral Therapy (ART) coverage in Canada was at 75% of Persons Living with HIV. Forecasted data through 2028 indicates stability in ART coverage, remaining constant at 75% from 2024 to 2027, before showing a modest increase to 76% in 2028. This reflects a stagnant growth trend with no significant year-on-year variation until a slight positive change in 2028.

Future trends to watch for include:

Potential policy changes impacting healthcare funding and access to antiretroviral drugs.
Advancements in medical technology that may enhance treatment accessibility.
Changes in public health initiatives aimed at increasing awareness and diagnosis of HIV.
Impact of social determinants of health on HIV prevention and treatment.